Cargando…
Aspirin in primary prevention of cardiovascular disease in diabetes
It is well established that people with diabetes are at an increased risk of cardiovascular disease compared with those without diabetes. Although the protective role of aspirin in secondary prevention is well documented, its role in primary prevention of cardiovascular disease in people with diabet...
Autores principales: | Papazafiropoulou, Athanasia K., Melidonis, Andreas, Antonopoulos, Stavros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487832/ https://www.ncbi.nlm.nih.gov/pubmed/36161214 http://dx.doi.org/10.5114/amsad.2021.105596 |
Ejemplares similares
-
Diabetes and dementia – the two faces of Janus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020) -
The COVID-19 pandemic and diabetes mellitus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020) -
Telemedicine and diabetes during the COVID-19 era
por: Papazafiropoulou, Athanasia
Publicado: (2022) -
Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
por: Li, Xiao-Ying, et al.
Publicado: (2022) -
Ketone bodies and the heart
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)